Showing results (41-50 of 78) with videos related to
Sort By:
Pageof 8
Expert Review of Clinical Pharmacology|February 1, 2024
Pharmacokinetic correlates of clinical response in a naturalistic sample of escitalopram-treated patientsNicholas Kasperk, Ekkehard Haen, Christoph Hiemke, et al.The Journal of Investigative Dermatology|January 29, 2005
Ultraviolet B-induced DNA damage in human epidermis is modified by the antioxidants ascorbic acid and D-alpha-tocopherolMarianne Placzek, Sabine Gaube, Urs Kerkmann, et al.Psychoneuroendocrinology|July 25, 2016
Body mass index (BMI) but not body weight is associated with changes in the metabolism of risperidone; A pharmacokinetics-based hypothesisMichael Paulzen, Ekkehard Haen, Benedikt Stegmann, et al.British Journal of Clinical Pharmacology|July 6, 2024
Discovering interactions in polypharmacy: Impact of metamizole on the metabolism of quetiapineFabian Watermeyer, Arnim Johannes Gaebler, Irene Neuner, et al.British Journal of Clinical Pharmacology|February 5, 2017
Cytochrome P450-mediated interaction between perazine and risperidone: implications for antipsychotic polypharmacyMichael Paulzen, Ekkehard Haen, Christoph Hiemke, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 21, 2017
Pharmacokinetics of risperidone in different application forms - Comparing long-acting injectable and oral formulationsGeorgios Schoretsanitis, Jose de Leon, Ekkehard Haen, et al.Expert Review of Clinical Pharmacology|March 31, 2025
Effects of the augmentation with quetiapine or olanzapine on the metabolism of duloxetine: a retrospective analysisNele Römer, Arnim Johannes Gaebler, Irene Neuner, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|May 6, 2015
Melperone but not bisoprolol or metoprolol is a clinically relevant inhibitor of CYP2D6: evidence from a therapeutic drug monitoring surveyGudrun Hefner, Stefan Unterecker, Mohamed E E Shams, et al.Pharmacopsychiatry|August 9, 2020
Lack of Smoking Effects on Pharmacokinetics of Oral Paliperidone-analysis of a Naturalistic Therapeutic Drug Monitoring SampleGeorgios Schoretsanitis, Ekkehard Haen, Andreas Conca, et al.European Archives of Psychiatry and Clinical Neuroscience|March 30, 2019
Pharmacokinetic correlates of venlafaxine: associated adverse reactionsGeorgios Schoretsanitis, Ekkehard Haen, Christoph Hiemke, et al.Pageof 8